Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)
China
· Delayed Price · Currency is CNY 15.81
-0.18 (-1.13%)
At close: Mar 9, 2026
SHA:600521 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 23,561 | 25,895 | 21,592 | 32,429 | 32,246 | 49,180 | Upgrade
|
| Market Cap Growth | 4.29% | 19.93% | -33.42% | 0.57% | -34.43% | 115.47% | Upgrade
|
| Enterprise Value | 29,844 | 31,481 | 27,591 | 37,869 | 35,435 | 51,438 | Upgrade
|
| Last Close Price | 15.81 | 17.66 | 14.33 | 21.08 | 20.79 | 32.14 | Upgrade
|
| PE Ratio | 49.54 | 23.14 | 26.00 | 27.77 | 66.14 | 52.89 | Upgrade
|
| Forward PE | 28.23 | 17.02 | 15.44 | 24.43 | 20.78 | 90.52 | Upgrade
|
| PS Ratio | 2.71 | 2.71 | 2.60 | 3.92 | 4.85 | 7.58 | Upgrade
|
| PB Ratio | 2.45 | 2.87 | 2.62 | 4.19 | 4.76 | 7.31 | Upgrade
|
| P/TBV Ratio | 2.85 | 3.39 | 3.13 | 5.06 | 5.84 | 8.73 | Upgrade
|
| P/FCF Ratio | - | 81.09 | 34.57 | - | - | 176.29 | Upgrade
|
| P/OCF Ratio | 24.86 | 11.92 | 9.74 | 26.10 | 34.36 | 31.62 | Upgrade
|
| PEG Ratio | - | 1.29 | 1.29 | 1.29 | 1.29 | 1.29 | Upgrade
|
| EV/Sales Ratio | 3.43 | 3.30 | 3.32 | 4.58 | 5.33 | 7.93 | Upgrade
|
| EV/EBITDA Ratio | 16.77 | 12.54 | 12.89 | 16.98 | 33.74 | 27.87 | Upgrade
|
| EV/EBIT Ratio | 37.46 | 19.38 | 20.28 | 24.00 | 70.52 | 37.41 | Upgrade
|
| EV/FCF Ratio | -31.21 | 98.59 | 44.17 | - | - | 184.39 | Upgrade
|
| Debt / Equity Ratio | 0.80 | 0.83 | 0.83 | 0.88 | 0.82 | 0.60 | Upgrade
|
| Debt / EBITDA Ratio | 4.33 | 2.96 | 3.20 | 3.01 | 5.18 | 2.19 | Upgrade
|
| Debt / FCF Ratio | - | 23.42 | 10.98 | - | - | 14.52 | Upgrade
|
| Net Debt / Equity Ratio | 0.65 | 0.65 | 0.66 | 0.68 | 0.54 | 0.27 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.52 | 2.34 | 2.53 | 2.36 | 3.47 | 1.00 | Upgrade
|
| Net Debt / FCF Ratio | -6.48 | 18.42 | 8.68 | -4.91 | -2.44 | 6.59 | Upgrade
|
| Asset Turnover | 0.43 | 0.49 | 0.45 | 0.49 | 0.47 | 0.55 | Upgrade
|
| Inventory Turnover | 0.96 | 1.09 | 0.99 | 1.04 | 1.05 | 1.04 | Upgrade
|
| Quick Ratio | 0.70 | 0.82 | 0.74 | 0.91 | 0.90 | 1.39 | Upgrade
|
| Current Ratio | 1.32 | 1.42 | 1.40 | 1.65 | 1.61 | 2.26 | Upgrade
|
| Return on Equity (ROE) | 4.79% | 12.82% | 10.22% | 16.20% | 7.12% | 15.91% | Upgrade
|
| Return on Assets (ROA) | 2.45% | 5.22% | 4.63% | 5.87% | 2.21% | 7.25% | Upgrade
|
| Return on Invested Capital (ROIC) | 3.20% | 8.60% | 7.57% | 10.49% | 3.23% | 13.94% | Upgrade
|
| Return on Capital Employed (ROCE) | 5.50% | 11.40% | 10.30% | 11.80% | 4.50% | 13.60% | Upgrade
|
| Earnings Yield | 1.99% | 4.32% | 3.85% | 3.60% | 1.51% | 1.89% | Upgrade
|
| FCF Yield | -4.06% | 1.23% | 2.89% | -3.31% | -4.64% | 0.57% | Upgrade
|
| Dividend Yield | 1.56% | 1.42% | 1.40% | 1.14% | 0.48% | 0.62% | Upgrade
|
| Payout Ratio | 114.99% | 42.48% | 66.95% | 27.26% | 79.42% | 42.25% | Upgrade
|
| Buyback Yield / Dilution | 0.47% | 0.52% | 0.19% | -1.80% | 1.30% | -4.58% | Upgrade
|
| Total Shareholder Return | 2.03% | 1.94% | 1.58% | -0.66% | 1.78% | -3.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.